Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease

References

Page 1

	Year	Citations
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Ganesh Raghu, Harold R. Collard, Jim Egan, American Journal of Respiratory and Critical Care Medicine	2011	7.1K
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Journal of Clinical Oncology	2008	3.2K
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Journal of Clinical Oncology	2004	2.4K
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Edward S. Kim, Vera Hirsh, Tony Mok, The Lancet Non-small-cell Lung CancerMedicineMetronomic TherapyClinical TrialsBronchial Neoplasm	2008	1.2K
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Jin Woo Song, Sang‐Bum Hong, Cheong-Su Lim, European Respiratory Journal Acute Lung InjuryAsthmaAntifibrotic TherapyInflammatory Lung DiseaseAdvanced Lung Disease	2010	772
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features D. S. Kim, Joo Hun Park, B. K. Park, European Respiratory Journal Acute Lung InjuryFibrosisAcute ExacerbationsInflammatory Lung DiseaseAdvanced Lung Disease	2005	492
Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten, Journal of Clinical Oncology Cancer QualityGemcitabine Plus CarboplatinCancer ManagementPathologyPharmacotherapy	2009	289
Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg, Journal of Clinical Oncology	2005	215
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias Yuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, Lung Cancer MedicineCancer ManagementWeekly PaclitaxelBronchial NeoplasmCancer Treatment	2010	145
Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes Masako Chiyo, Yasuo Sekine, Takekazu Iwata, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyAdvanced Lung DiseaseMedicineThoracic SurgeryPulmonary Fibrosis	2003	124

Page 1